Isabelle Ayoub - Concepedia

Author

Isabelle Ayoub

The Ohio State University Wexner Medical Center ORCID

Also Known As

Gauckler, Philipp, I Ayoub, I. Ayoub, Isabelle Ayoub, Isabelle M Ayoub, Isabelle M. Ayoub

110

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Wexner Medical Center University of Michigan The Ohio State University University of Pennsylvania University of North Carolina at Chapel Hill

About

Isabelle Ayoub is an author at The Ohio State University Wexner Medical Center specializing in medicine, glomerulonephritis, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	666
2	Nephrology	10	10	576
3	Immunology	5	5	102
4	Health Sciences	1	1	11
5	Biostatistics	1	1	42

Isabelle Ayoub

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS Brad H. Rovin, Isabelle Ayoub, Tak Mao Chan, Kidney International	2024	337
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Jürgen Floege, Sean Barbour, Daniel Cattran, Kidney International	2019	257
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy Jonathan Barratt, Richard Lafayette, Jens Kristensen, Kidney International	2022	205
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Brad H. Rovin, Dawn J. Caster, Daniel C. Cattran, Kidney International	2019	181
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease Laura Mariani, Andrew S. Bomback, Pietro A. Canetta, American Journal of Kidney Diseases Glomerular DiseaseGlomerulonephritisHemodialysisRenal FunctionRenal Disease	2018	131
Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19 Edward Calomeni, Anjali A. Satoskar, Isabelle Ayoub, Kidney International Viral DiagnosticsCovid-19 PandemicVirologyCovid-19 EpidemiologyMultivesicular Bodies	2020	79
Staphylococcus Infection–Associated GN – Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort Anjali A. Satoskar, Sarah Suleiman, Isabelle Ayoub, Clinical Journal of the American Society of Nephrology	2016	76
Health-related quality of life in glomerular disease Pietro A. Canetta, Jonathan P. Troost, Shannon Mahoney, Kidney International Glomerular DiseaseGlomerulonephritisHemodialysisQuality Of LifeRenal Disease	2019	59

Page 1